Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications

NANot yet recruitingINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

April 5, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

November 1, 2026

Conditions
Portal Hypertension
Interventions
DEVICE

The intraparenchymal portal vein covered stent

The intraparenchymal portal vein covered stent, produced by Shanghai Shenqi Medical Technology Co., Ltd., is used for a transjugular approach. It establishes an artificial shunt between the hepatic vein and the main branches of the portal vein within the liver. This helps in reducing portal venous pressure and alleviating or improving the symptoms of portal hypertension and its complications, such as variceal bleeding, gastropathy, refractory ascites, and/or hepatic hydrothorax.

DEVICE

TIPS Covered Stent System GORE

The GORE® VIATORR® Transjugular Intrahepatic Portosystemic Shunt (TIPS) Covered Stent consists of an implantable covered stent and a percutaneous delivery catheter.

Trial Locations (1)

Unknown

Southern Medical University Nanfang Hospital, Guangzhou

All Listed Sponsors
lead

Shanghai Shenqi Medical Technology Co., Ltd

INDUSTRY

NCT06320912 - Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications | Biotech Hunter | Biotech Hunter